体质量与C1q肿瘤坏死因子相关蛋白1在心肌梗死患者中的交互作用

doi:10.3969/j.issn.1674-8115.2022.06.013

上海交通大学学报（医学版） ›› 2022, Vol. 42 ›› Issue (6): 786-791.doi: 10.3969/j.issn.1674-8115.2022.06.013

• 论著 · 临床研究 • 上一篇

体质量与C1q肿瘤坏死因子相关蛋白1在心肌梗死患者中的交互作用

胡晓(), 张鑫, 谷阳()

南京医科大学附属淮安第一医院心内科，淮安 223300

收稿日期:2022-01-20 接受日期:2022-06-01 出版日期:2022-06-28 发布日期:2022-08-19
通讯作者: 谷阳 E-mail:bingdianzb@126.com;guyang1028@163.com
作者简介:胡晓（1990—），男，主治医师，博士；电子信箱：bingdianzb@126.com。
基金资助:
中华国际医学交流基金会“心血管多学科整合思维研究基金”(Z-2016-23-2101-46);淮安市自然科学研究计划(HAB202025)

Study on the interaction between body weight and C1q tumour necrosis factor-related protein 1 in patients with myocardial infarction

HU Xiao(), ZHANG Xin, GU Yang()

Department of Cardiology, The Affiliated Huaian No. 1 People's Hospital of Nanjing Medical University, Huai'an 223300, China

Received:2022-01-20 Accepted:2022-06-01 Online:2022-06-28 Published:2022-08-19
Contact: GU Yang E-mail:bingdianzb@126.com;guyang1028@163.com
Supported by:
Cardiovascular Multidisciplinary Thinking Research Fund of China International Medical Foundation(Z-2016-23-2101-46);Natural Science Research Program of Huai'an(HAB202025)

摘要/Abstract

摘要：

目的·探讨体质量与血清C1q肿瘤坏死因子相关蛋白1（C1q tumor necrosis factor-related protein 1，CTRP1）水平间的关系，以及其对ST段抬高型心肌梗死（ST-segment elevation myocardial infarction，STEMI）患者预后的影响。方法·选取2018年1月—2020年1月在南京医科大学附属淮安第一医院确诊的200例STEMI患者，收集并分析患者的基本资料、实验室检测指标及心功能指标。患者出院后，需继续口服药物并定期行门诊或电话随访。根据出院后1年内是否发生严重不良事件（serious adverse event，SAE），将患者分为SAE组和无SAE组。采用多因素Logistic回归模型分析STEMI患者发生SAE的影响因素。采用森林图分析患者的性别、年龄、体质量与血清CTRP1水平的交互作用。结果·共192例患者完成随访。其中，24例（12.5%）患者发生SAE。与无SAE组相比，SAE组患者的年龄更大［（67.08±10.30）岁vs（62.99±9.04）岁，P=0.043］、体质量更低［（65.41±9.45）kg vs（70.49±10.23）kg，P=0.023）］、CTRP1水平较高［（21.59±4.48）ng/mL vs （17.67±5.87）ng/mL，P=0.002）］。经校正性别、年龄后，多因素Logistic回归分析显示高CTRP1水平是STEMI患者发生SAE的危险因素（P=0.003），而体质量不影响患者SAE的发生（P>0.05）。亚组分析的结果显示，体质量与CTRP1之间存在交互作用（P=0.011），且CTRP1水平是低体质量患者发生SAE的危险因素（HR=22.303，P=0.003）。结论·STEMI患者的体质量与血清CTRP1水平间存在交互作用；低体质量STEMI患者的血清CTRP1水平越高，则预后越差。

Abstract:

Objective·To investigate relationship between body weight and serum level of C1q tumor necrosis factor-related protein 1 (CTRP1), and its effect on the prognosis of patients with ST-segment elevation myocardial infarction (STEMI).

Methods·A total of 200 patients diagnosed as STEMI in the Affiliated Huaian No.1 People's Hospital of Nanjing Medical University from January 2018 to January 2020 were selected. Their basic data, laboratory indexes and cardiac function indexes were collected and analyzed. After discharge, patients should continue to take oral drugs and have regular outpatient or telephone follow-up. According to whether serious adverse event (SAE) occurred or not within 1 year after discharge, patients were divided into SAE group and non-SAE group. Multivariate Logistic regression model was used to analyze the influencing factors of SAE in STEMI patients. The interaction between gender, age and body weight of patients and the serum level of CTRP1 was analyzed by forest plot.

Results·A total of 192 patients were followed up. Among them, 24 patients (12.5%) developed SAE. Compared with the non-SAE group, patients in the SAE group were older [(67.08±10.30) years vs (62.99±9.04) years, P=0.043], had lower body weight [(65.41±9.45) kg vs (70.49±10.23) kg, P=0.023)], and had higher CTRP1 levels [(21.59±4.48) ng/mL vs (17.67±5.87) ng/mL, P=0.002)]. After adjusting for gender and age, multivariate Logistic regression analysis showed that high CTRP1 level was a risk factor for the incidence of SAE in STEMI patients (P=0.003), while body weight had no effect on the incidence of SAE (P>0.05). The results of subgroup analysis showed that there was an interaction between body weight and CTRP1 (P=0.011), and CTRP1 level was a risk factor for SAE occurring in patients with lower body weight (HR=22.303, P=0.003).

Conclusion·There is an interaction between body weight and serum CTRP1 level in STEMI patients. The higher the level of serum CTRP1 in STEMI patients with lower body weight, the worse the prognosis they have.

Key words: C1q tumor necrosis factor-related protein 1 (CTRP1), ST-segment elevation myocardial infarction (STEMI), interaction, serious adverse event (SAE)

中图分类号:

R541.4

胡晓, 张鑫, 谷阳. 体质量与C1q肿瘤坏死因子相关蛋白1在心肌梗死患者中的交互作用[J]. 上海交通大学学报（医学版）, 2022, 42(6): 786-791.

HU Xiao, ZHANG Xin, GU Yang. Study on the interaction between body weight and C1q tumour necrosis factor-related protein 1 in patients with myocardial infarction[J]. Journal of Shanghai Jiao Tong University (Medical Science), 2022, 42(6): 786-791.

图/表 3

参考文献 25

1	HIRAKAWA Y, LAM T H, WELBORN T, et al. The impact of body mass index on the associations of lipids with the risk of coronary heart disease in the Asia Pacific region[J]. Prev Med Rep, 2015, 3: 79-82.
2	BALSAN G A, VIEIRA J L, OLIVEIRA A M, et al. Relationship between adiponectin, obesity and insulin resistance[J]. Rev Assoc Med Bras (1992), 2015, 61(1): 72-80.
3	JENSEN M D, RYAN D H, APOVIAN C M, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society[J]. Circulation, 2014, 129(25 Suppl 2): S102-S138.
4	中华医学会内分泌学分会肥胖学组. 中国成人肥胖症防治专家共识[J]. 中华内分泌代谢杂志, 2011, 27(9): 711-717.
	Obesity Group of Endocrinology Society of Chinese Medical Association. Expert consensus on prevention for Chinese adult obesity[J]. Chin J Endocrinol Metab, 2011, 27(9): 711-717.
5	BENJUMEA M V, ESTRADA A, CURCIO C L. Estimation equations for the height of Colombian elders using knee height[J]. Biomedica, 2019, 39(4): 639-646.
6	TANG J N, SHEN D L, LIU C L, et al. Plasma levels of C1q/TNF-related protein 1 and interleukin 6 in patients with acute coronary syndrome or stable angina pectoris[J]. Am J Med Sci, 2015, 349(2): 130-136.
7	JEON J H, KIM K Y, KIM J H, et al. A novel adipokine CTRP1 stimulates aldosterone production[J]. FASEB J, 2008, 22(5): 1502-1511.
8	ENGELI S, BÖHNKE J, GORZELNIAK K, et al. Weight loss and the renin-angiotensin-aldosterone system[J]. Hypertension, 2005, 45(3): 356-362.
9	中华医学会心血管病学分会, 中华心血管病杂志编辑委员会. 急性ST段抬高型心肌梗死诊断和治疗指南[J]. 中华心血管病杂志, 2015, 43(5): 380-393.
	Chinese Society of Cardiology of Chinese Medical Association, Editorial Board of Chinese Journal of Cardiology. Guidelines for the diagnosis and management of patients with ST-segment elevation myocardial infarction[J]. Chin J Cardiol, 2015,43(5):380-393.
10	国家体育总局. 2010年国民体质监测公报[EB/OL]. (2011-09-02) [2022-01-18]. https://www.sport.gov.cn/n4/n145/c328627/content_2.html.
	General Administration of Sports of China. 2010 National physical fitness monitoring bulletin[EB/OL]. (2011-09-02) [2022-01-18]. https://www.sport.gov.cn/n4/n145/c328627/content_2.html.
11	KERSBERGEN I, ROBINSON E. Blatant dehumanization of people with obesity[J]. Obesity (Silver Spring), 2019, 27(6): 1005-1012.
12	SONG X, TABÁK A G, ZETHELIUS B, et al. Obesity attenuates gender differences in cardiovascular mortality[J]. Cardiovasc Diabetol, 2014, 13: 144.
13	SHIGA T, KOHRO T, YAMASAKI H, et al. Body mass index and sudden cardiac death in Japanese patients after acute myocardial infarction: data from the JCAD study and HIJAMI-Ⅱ registry[J]. J Am Heart Assoc, 2018, 7(14): e008633.
14	王欢欢, 赵雪燕, 高展, 等. 体重指数对行介入治疗的急性ST段抬高型心肌梗死患者长期预后的影响[J]. 中国循环杂志, 2017, 32(4): 348-352.
	WANG H H, ZHAO X Y, GAO Z, et al. Impact of body mass index on long-term prognosis in patients of acute ST-segment elevation myocardial infarction after percutaneous coronary intervention[J]. Chin Circ J, 2017, 32(4): 348-352.
15	WANG Z J, ZHOU Y J, GALPER B Z, et al. Association of body mass index with mortality and cardiovascular events for patients with coronary artery disease: a systematic review and meta-analysis[J]. Heart, 2015, 101(20): 1631-1638.
16	KANEKO H, YAJIMA J, OIKAWA Y, et al. Obesity paradox in Japanese patients after percutaneous coronary intervention: an observation cohort study[J]. J Cardiol, 2013, 62(1): 18-24.
17	KANEMURA N, SHIBATA R, OHASHI K, et al. C1q/TNF-related protein 1 prevents neointimal formation after arterial injury[J]. Atherosclerosis, 2017, 257: 138-145.
18	SCHÄFFLER A, BUECHLER C. CTRP family: linking immunity to metabolism[J]. Trends Endocrinol Metab, 2012, 23(4): 194-204.
19	BARCHETTA I, CIMINI F A, CICCARELLI G, et al. Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation[J]. J Endocrinol Invest, 2019, 42(11): 1257-1272.
20	DING Q X, WHITE S P, LING C, et al. Resistin and cardiovascular disease[J]. Trends Cardiovasc Med, 2011, 21(1): 20-27.
21	KIM K Y, KIM H Y, KIM J H, et al. Tumor necrosis factor-α and interleukin-1β increases CTRP1 expression in adipose tissue[J]. FEBS Lett, 2006, 580(16): 3953-3960.
22	孙恒, 齐潇雁, 肖新华. 肥胖对动脉粥样硬化的影响[J]. 中国动脉硬化杂志, 2019, 27(10): 829-834.
	SUN H, QI X Y, XIAO X H. The impact of obesity on atherosclerosis[J]. Chin J Arterioscler, 2019, 27(10): 829-834.
23	MUENDLEIN A, LEIHERER A, SAELY C, et al. The novel adipokine CTRP1 is significantly associated with the incidence of major adverse cardiovascular events[J]. Atherosclerosis, 2019, 286: 1-6.
24	KIM D, PARK S Y. C1q and TNF related protein 1 regulates expression of inflammatory genes in vascular smooth muscle cells[J]. Genes Genomics, 2019, 41(4): 397-406.
25	GU Y, HU X, GE P B, et al. CTRP1 aggravates cardiac dysfunction post myocardial infarction by modulating TLR4 in macrophages[J]. Front Immunol, 2021, 12: 635267.

Item	Non-SAE group （n=168）	SAE group （n=24）	t/χ² value	P value
Age/year	62.99±9.04	67.08±10.30	-2.037	0.043
Gender （male/female）/n	105/63	13/11	0.616	0.433
Body weight/kg	70.49±10.23	65.41±9.45	2.297	0.023
BMI/（kg·m^-2）	23.30±2.30	23.49±1.91	-0.373	0.709
Past medical history/n（%）
History of hypertension	93 （55.4）	16 （66.7）	1.094	0.295
History of diabetes mellitus	67 （39.9）	6 （25.0）	1.973	0.160
Family history of coronary heart disease	80 （47.6）	12 （50.0）	0.048	0.827
History of smoking	96 （57.1）	9 （37.5）	3.270	0.071
IRA （LAD/LCX/RCA）/n	69/45/54	10/7/7	0.104	0.949
Creatinine/（µmol·L^-1）	64.08±12.98	62.03±14.73	0.710	0.478
FBG/（mmol·L^-1）	6.35±1.34	6.21±1.13	0.472	0.637
LDL-C/（mmol·L^-1）	3.14±0.79	2.98±0.69	0.979	0.329
CTRP1/（ng·mL^-1）	17.67±5.87	21.59±4.48	-3.144	0.002
LVEF/%	49.40±9.89	50.75±8.65	-0.635	0.526

Item	Non-SAE group （n=168）	SAE group （n=24）	t/χ² value	P value
Age/year	62.99±9.04	67.08±10.30	-2.037	0.043
Gender （male/female）/n	105/63	13/11	0.616	0.433
Body weight/kg	70.49±10.23	65.41±9.45	2.297	0.023
BMI/（kg·m^-2）	23.30±2.30	23.49±1.91	-0.373	0.709
Past medical history/n（%）
History of hypertension	93 （55.4）	16 （66.7）	1.094	0.295
History of diabetes mellitus	67 （39.9）	6 （25.0）	1.973	0.160
Family history of coronary heart disease	80 （47.6）	12 （50.0）	0.048	0.827
History of smoking	96 （57.1）	9 （37.5）	3.270	0.071
IRA （LAD/LCX/RCA）/n	69/45/54	10/7/7	0.104	0.949
Creatinine/（µmol·L^-1）	64.08±12.98	62.03±14.73	0.710	0.478
FBG/（mmol·L^-1）	6.35±1.34	6.21±1.13	0.472	0.637
LDL-C/（mmol·L^-1）	3.14±0.79	2.98±0.69	0.979	0.329
CTRP1/（ng·mL^-1）	17.67±5.87	21.59±4.48	-3.144	0.002
LVEF/%	49.40±9.89	50.75±8.65	-0.635	0.526

Factor	β	S.E.	Wald	P value	OR	95%CI
Factor	β	S.E.	Wald	P value	OR	Lower limit	Upper limit
Gender
Male	‒	‒	‒	‒	Ref	‒	‒
Female	0.452	0.468	0.932	0.334	1.571	0.628	3.931
Age
≤63 years old	‒	‒	‒	‒	Ref	‒	‒
>63 years old	0.280	0.459	0.371	0.542	1.323	0.538	3.252
Body weight
≤70.75 kg	‒	‒	‒	‒	Ref	‒	‒
>70.75 kg	-0.951	0.491	3.756	0.053	0.386	0.148	1.011
CTRP1
≤17.95 ng·mL^-1	‒	‒	‒	‒	Ref	‒	‒
>17.95 ng·mL^-1	1.568	0.536	8.558	0.003	4.797	1.678	13.715
Constant	-2.881	0.618	21.699	0.000	0.056	‒	‒

Factor	β	S.E.	Wald	P value	OR	95%CI
Factor	β	S.E.	Wald	P value	OR	Lower limit	Upper limit
Gender
Male	‒	‒	‒	‒	Ref	‒	‒
Female	0.452	0.468	0.932	0.334	1.571	0.628	3.931
Age
≤63 years old	‒	‒	‒	‒	Ref	‒	‒
>63 years old	0.280	0.459	0.371	0.542	1.323	0.538	3.252
Body weight
≤70.75 kg	‒	‒	‒	‒	Ref	‒	‒
>70.75 kg	-0.951	0.491	3.756	0.053	0.386	0.148	1.011
CTRP1
≤17.95 ng·mL^-1	‒	‒	‒	‒	Ref	‒	‒
>17.95 ng·mL^-1	1.568	0.536	8.558	0.003	4.797	1.678	13.715
Constant	-2.881	0.618	21.699	0.000	0.056	‒	‒

[1]	胡培堃, 何杰, 吴连明, 葛恒, 许建荣, 卜军. ST段抬高型心肌梗死患者微血管阻塞对左室功能及预后的影响[J]. 上海交通大学学报(医学版), 2021, 41(2): 173-179.
[2]	高亚洁, 马文坤, 高程洁, 周翌, 潘静薇. 心肌应变对急性ST段抬高型心肌梗死后心室重构的预测价值探讨[J]. 上海交通大学学报(医学版), 2021, 41(11): 1478-1484.
[3]	冯泽豪1，张清1，柴烨子1，苏璇1，孙宝航行1，刘启明1，严福华2，姜萌1#，卜军1#. 吸烟对急性ST段抬高型心肌梗死急性期心肌损伤及预后的影响[J]. 上海交通大学学报(医学版), 2020, 40(5): 573-582.
[4]	梁伟，田书雅，任妍，沈琳辉. 老年男性代谢综合征患者血清CTRP1水平及其与血清脂联素水平的关系[J]. 上海交通大学学报（医学版）, 2017, 37(2): 218-.
[5]	张明亮，张俊峰. 血栓抽吸术在急性ST段抬高型心肌梗死治疗中的研究进展[J]. 上海交通大学学报（医学版）, 2016, 36(11): 1664-.
[6]	杜易敏，陈丽萍，翁维民，等. 空气、水和釉液在不同基底色时对全瓷贴面颜色的影响[J]. 上海交通大学学报（医学版）, 2015, 35(4): 506-.
[7]	陶晶, 仇剑崟, 顾红亮, 等. ESR1基因与5-HTT基因多态性的交互作用对女性围绝经期抑郁障碍的影响[J]. , 2012, 32(6): 766-.

体质量与C1q肿瘤坏死因子相关蛋白1在心肌梗死患者中的交互作用

Study on the interaction between body weight and C1q tumour necrosis factor-related protein 1 in patients with myocardial infarction

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

图/表 3

参考文献 25

相关文章 7

编辑推荐

Metrics